Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy.
Arai Y, Takeda J, Aoki K, Kondo T, Takahashi S, Onishi Y, Ozawa Y, Aotsuka N, Kouzai Y, Nakamae H, Ota S, Nakaseko C, Yamaguchi H, Kato K, Atsuta Y, Takami A; AML and MDS Working Group of the Japan Society for Hematopoietic Cell Transplantation. Arai Y, et al. Blood. 2015 Jul 16;126(3):415-22. doi: 10.1182/blood-2015-04-642652. Epub 2015 Jun 1. Blood. 2015. PMID: 26031916 Free PMC article.
Risk factors for hypogammaglobulinemia after allo-SCT.
Arai Y, Yamashita K, Mizugishi K, Kondo T, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A. Arai Y, et al. Bone Marrow Transplant. 2014 Jun;49(6):859-61. doi: 10.1038/bmt.2014.28. Epub 2014 Mar 3. Bone Marrow Transplant. 2014. PMID: 24583624 No abstract available.
Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy.
Arai Y, Aoki K, Takeda J, Kondo T, Eto T, Ota S, Hashimoto H, Fukuda T, Ozawa Y, Kanda Y, Kato C, Kurokawa M, Iwato K, Onizuka M, Ichinohe T, Atsuta Y, Takami A; AML and MDS Working Group of Japan Society for Hematopoietic Cell Transplantation. Arai Y, et al. J Hematol Oncol. 2015 Sep 4;8:102. doi: 10.1186/s13045-015-0201-x. J Hematol Oncol. 2015. PMID: 26337829 Free PMC article.
Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.
Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Kaida K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, Murata M; GVHD working group of the Japan Society for Hematopoietic Cell Transplantation. Arai Y, et al. Bone Marrow Transplant. 2016 Jan;51(1):96-102. doi: 10.1038/bmt.2015.205. Epub 2015 Sep 14. Bone Marrow Transplant. 2016. PMID: 26367230 Clinical Trial.
4,199 results